ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

China’s Pharmaron bags analysis firm Xceleron

by Jean-François Tremblay
January 23, 2017 | APPEARED IN VOLUME 95, ISSUE 4

The Beijing-based contract research firm Pharmaron has agreed to buy Xceleron, a provider of mass spectrometry services based in Germantown, Md. According to Pharmaron, Xceleron has developed accelerator mass-spectrometry technology that uses carbon-14 ion counting to analyze very small drug samples. The Chinese firm expects the technology to complement its U.K.-based offerings in the area of radiolabeled compound manufacturing and radiolabeled metabolism services. Pharmaron was formed in 2003 and employs about 4,000 people.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment